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hiPSCs and hESCs are thought to display subtle genetic and epigenetic variability. Recently in Nature Cell
Biology, Wang et al. (2013) demonstrated a role for TET1 during reprogramming of human cells and showed
that hiPSCs lack appropriate 5hmCmarks in subtelomeric regions, contributing to epigenetic variation com-
mon to hiPSCs.The ability to reprogram cell fate by the
overexpression of a handful of genes
has opened the door to limitless pos-
sibilities for modeling development or
diseases in vitro and eventual patient-
specific clinical applications. Yamanaka
and colleagues first described this para-
digm by overexpressing four transcription
factors in fibroblasts, leading to their con-
version to a pluripotent state. Since then,
pluripotent cells derived by induction
(induced pluripotent stem cells, or iPSCS)
have been extensively compared to their
embryo-derived counterparts (embryonic
stem cells, or ESCs). Many studies have
identified epigenetic and transcriptional
differences between these types of plurip-
otent stem cells (Chin et al., 2009; Lister
et al., 2011; Ohi et al., 2011; Ruiz et al.,
2012), while others have suggested that
these differences are no more dramatic
than those found when comparing
different ESC lines (or iPSC lines) to
each other (Bock et al., 2011). Ultimately,
high-quality human iPSCs and ESCs
could be functionally equivalent, while
potentially still distinguishable at the
molecular level depending on the resolu-
tion of the analysis and the number of
lines analyzed.
In the present study, Wang et al. (2013)
exploit high-resolution analyses of DNA
methylation to confirm and extend
previous findings that hiPSCs are distin-
guished from hESCs by altered methyl-
ation status of subtelomeric DNA. Previ-
ously, three groups provided compelling
evidence that hiPSCs appear to have
aberrant patterns of 5-methyl-Cytosine
(5mC) modification within subtelomeric
DNA regions (Lister et al., 2011; Ohi et al.,10 Cell Stem Cell 13, July 3, 2013 ª2013 Else2011; Ruiz et al., 2012). This patterning
was thought to result from inefficient
erasing and/or rewriting of the methylome
during reprogramming, reflecting an
epigenetic memory of the somatic state
from which they were derived. However,
since these previous studies relied upon
traditional bisulfite sequencing, they did
not distinguish 5mC from 5-hydroxy-
methyl-Cytosine (5hmC), a mark that has
recently been shown to be a signature
aspect of the methyl-DNA repertoire and
important for gene regulation. Wang et al.
first found that TET1, a key enzyme that
converts 5mC to 5hmC, is strongly
induced during reprogramming, and that
blocking its expression abrogated the
reprogramming process. This suggests
that the selective conversion of 5mC to
5hmC is important for acquisition of the
pluripotent state (Wang et al., 2013).
Similar results were obtained previously
forTet1andTet2 inmurine reprogramming
(Koh et al., 2011). Interestingly, knocking
down TET1 in human pluripotent cells
had little effect on the pluripotent state,
suggesting that the key role for TET1
occurs during the initial conversion of
5hmC during reprogramming and does
not involve the maintenance of this mark
(Wang et al., 2013).
Extensive profiling of 5hmC in fibro-
blasts, hiPSCs, and hESCs demonstrated
that, out of 372,423 regions that were en-
riched for 5hmC marks throughout the
genome, just 113 (0.03%) could be classi-
fied as differentially hydroxyl-methylated
regions (DhMRs) when drawn from com-
parisons between hiPSCs and hESCs.
The finding that such a tiny fraction of
the genome appeared to be differentiallyvier Inc.methylated is consistent with previous
reports and is further evidence of the
remarkably faithful process that is
induced upon introduction of the Yama-
naka factors. On the other hand, 93% of
these DhMRs were hypohydroxymethy-
lated, which would indicate that the
reprogramming process appears to spe-
cifically fail to convert 5mC to 5hmC in
certain portions of the genome, leaving
these regions in a state more typical of
the somatic cells from which they came.
Furthermore, themajority of these DhMRs
tended to be localized to subtelomeric
regions of the genome.
These findings are interesting in light of
previous studies showing similar patterns
of 5mC in subtelomeric regions of hiPSCs
(Lister et al., 2011; Ruiz et al., 2012).
Remarkably, a list of nine genes observed
to be differently expressed in hiPSCs
versus hESCs by Ruiz et al. (2012)
highly overlaps with the list of sum-
marized hypomethylation hotspots pre-
sented inWang et al. The fact thatmultiple
labs using distinct cell lines came to
similar conclusions is strong evidence
that these subtelomeric regions are
indeed hotspots of reprogramming and
warrant further consideration as possible
proxies for defining the quality of PSCs
at the molecular level. This metric could
prove to be useful because no assay
currently exists to quantitatively assess
the quality of human pluripotent stem
cells. Regardless, the methylation status
of these hotspots across human pluripo-
tent stem cell lines is clear evidence
that, at a minimum, hiPSCs exhibit signif-
icantly more epigenetic variation than
existing hESCs.
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PreviewsThe data in Wang et al. might appear
to be confounding to previous studies
that did not find consistent DhMRs
between hESCs and hiPSCs. The
simplest explanation is that the molecu-
lar differences between these types of
pluripotent stem cells are quite subtle
(just 0.03% of 5hmC-enriched regions
in Wang et al., 2013). Therefore, studies
in which many lines have been com-
pared at low resolution (with Reduced
Resolution Bisulphite Sequencing or
DNA Methylation Arrays) did not identify
consistent differences (Bock et al.,
2011; Nazor et al., 2012), while those
that used high resolution (single nucleo-
tide) analyses on fewer lines have re-
ported differences (Lister et al., 2011;
Ohi et al., 2011; Ruiz et al., 2012; Wang
et al., 2013). Regardless, the more
compelling issue is why these subtelo-
meric domains are apparently difficult
to appropriately methylate during reprog-
ramming. Furthermore, can one take
advantage of this observation to learn
something about the basic mechanisms
of how the Yamanaka factors drive this
transformation? Numerous epigenetic
barriers to reprogramming have recently
been identified, partially explaining the
very low inefficiency of the process
(Watanabe et al., 2013). Wang et al. sug-
gest that activity of TET1 represents yet
another barrier to proper reprogramming
to the pluripotent state.The replication and organization of telo-
meres presents a serious engineering
problem for cells. The ends of chromo-
somes require their own unique machin-
ery to preserve the length and integrity
of telomeres, while isolating the subtelo-
mere domain from such machinations.
Among the panoply of reorganization
events that must occur during reprogram-
ming is the reestablishment of telomere
length by telomerase. Another recent
paper demonstrated that TRF1, a compo-
nent of the shelterin complex that main-
tains telomere integrity, was required for
reprogramming (Schneider et al., 2013).
Together with those of Wang et al., these
findings suggest that reorganizing telo-
meres during reprogramming is not just
a matter of restoring their length, but
also requires the activity of the shelterin
complex and epigenetic remodeling of
the subtelomeric domain. This latter reor-
ganization appears to fall somewhat short
in hiPSCs, affecting the expression of
several genes in these regions (TCERG1l,
TMEM132D, etc.) (Chin et al., 2009; Ruiz
et al., 2012; Wang et al., 2013). The key
unresolved issue is whether the small
degree of hypomethylation observed in
hiPSCs has a functional significance
or is inconsequential. Regardless, one
should take into account the increased
degree of epigenetic variability across
hiPSC lines when modeling disease or
development in vitro.Cell Stem CREFERENCES
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